View Item 

Show simple item record

Carotid artery thickness is associated with chronic use of highly active antiretroviral therapy in patients infected with human immunodeficiency virus: A 3.0 Tesla magnetic resonance imaging study
dc.contributor.authorLaBounty, TM
dc.contributor.authorHardy, WD
dc.contributor.authorFan, Z
dc.contributor.authorYumul, R
dc.contributor.authorLi, D
dc.contributor.authorDharmakumar, R
dc.contributor.authorConte, A Hernandez
dc.date.accessioned2016-09-17T23:54:38Z
dc.date.available2017-11-01T15:31:29Zen
dc.date.issued2016-08
dc.identifier.citationLaBounty, TM; Hardy, WD; Fan, Z; Yumul, R; Li, D; Dharmakumar, R; Conte, A Hernandez (2016). "Carotid artery thickness is associated with chronic use of highly active antiretroviral therapy in patients infected with human immunodeficiency virus: A 3.0 Tesla magnetic resonance imaging study." HIV Medicine 17(7): 516-523.
dc.identifier.issn1464-2662
dc.identifier.issn1468-1293
dc.identifier.urihttps://hdl.handle.net/2027.42/133594
dc.publisherWiley Periodicals, Inc.
dc.subject.othermagnetic resonance imaging
dc.subject.othercarotid artery disease
dc.subject.otherhighly active antiretroviral therapy
dc.subject.otherHIV
dc.subject.otherstroke
dc.titleCarotid artery thickness is associated with chronic use of highly active antiretroviral therapy in patients infected with human immunodeficiency virus: A 3.0 Tesla magnetic resonance imaging study
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMicrobiology and Immunology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/133594/1/hiv12351_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/133594/2/hiv12351.pdf
dc.identifier.doi10.1111/hiv.12351
dc.identifier.sourceHIV Medicine
dc.identifier.citedreferenceLo J, Abbara S, Shturman L et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV‐infected men. AIDS 2010; 24: 243 – 253.
dc.identifier.citedreferencevan Sighem AI, Gras LA, Reiss P, Brinkman K, deWolf F, Study ANOC. Life expectancy of recently diagnosed asymptomatic HIV‐infected patients approaches that of uninfected individuals. AIDS 2010; 24: 1527 – 1535.
dc.identifier.citedreferenceBenjamin LA, Bryer A, Emsley HC, Khoo S, Solomon T, Connor MD. HIV infection and stroke: current perspectives and future directions. Lancet Neurol 2012; 11: 878 – 890.
dc.identifier.citedreferenceOvbiagele B, Nath A. Increasing incidence of ischemic stroke in patients with HIV infection. Neurology 2011; 76: 444 – 450.
dc.identifier.citedreferenceRasmussen LD, Engsig FN, Christensen H et al. Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population‐based cohort study. AIDS 2011; 25: 1637 – 1646.
dc.identifier.citedreferenceFriis‐Moller N, Sabin CA, Weber R et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349: 1993 – 2003.
dc.identifier.citedreferenceGrinspoon S. Diabetes mellitus, cardiovascular risk, and HIV disease. Circulation 2009; 119: 770 – 772.
dc.identifier.citedreferenceHsue PY, Lo JC, Franklin A et al. Progression of atherosclerosis as assessed by carotid intima‐media thickness in patients with HIV infection. Circulation 2004; 109: 1603 – 1608.
dc.identifier.citedreferenceGrunfeld C, Delaney JA, Wanke C et al. Preclinical atherosclerosis due to HIV infection: carotid intima‐medial thickness measurements from the FRAM study. AIDS 2009; 23: 1841 – 1849.
dc.identifier.citedreferenceHsue PY, Ordovas K, Lee T et al. Carotid intima‐media thickness among human immunodeficiency virus‐infected patients without coronary calcium. Am J Cardiol 2012; 109: 742 – 747.
dc.identifier.citedreferencePapita A, Albu A, Fodor D, Itu C, Carstina D. Arterial stiffness and carotid intima‐media thickness in HIV infected patients. Med Ultrason 2011; 13: 127 – 134.
dc.identifier.citedreferencevan Vonderen MG, Smulders YM, Stehouwer CD et al. Carotid intima‐media thickness and arterial stiffness in HIV‐infected patients: the role of HIV, antiretroviral therapy, and lipodystrophy. J Acquir Immune Defic Syndr 2009; 50: 153 – 161.
dc.identifier.citedreferenceCurrier JS, Kendall MA, Zackin R et al. Carotid artery intima‐media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS 2005; 19: 927 – 933.
dc.identifier.citedreferenceBongiovanni M, Casana M, Cicconi P et al. Predictive factors of vascular intima media thickness in HIV‐positive subjects. J Antimicrob Chemother 2008; 61: 195 – 199.
dc.identifier.citedreferenceDuivenvoorden R, de Groot E, Elsen BM et al. In vivo quantification of carotid artery wall dimensions: 3.0‐Tesla MRI versus B‐mode ultrasound imaging. Circ Cardiovasc Imaging 2009; 2: 235 – 242.
dc.identifier.citedreferenceMartinez E, Mocroft A, Garcia‐Viejo MA et al. Risk of lipodystrophy in HIV‐1‐infected patients treated with protease inhibitors: a prospective cohort study. Lancet 2001; 357: 592 – 598.
dc.identifier.citedreferenceWilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz A, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837 – 1847.
dc.identifier.citedreferenceHarloff A, Zech T, Frydrychowicz A et al. Carotid intima‐media thickness and distensibility measured by MRI at 3 T versus high‐resolution ultrasound. Eur Radiol 2009; 19: 1470 – 1479.
dc.identifier.citedreferenceHayashi K, Mani V, Nemade A et al. Variations in atherosclerosis and remodeling patterns in aorta and carotids. J Cardiovasc Magn Reson 2010; 12: 10.
dc.identifier.citedreferenceLaw MG, Friis‐Moller N, El‐Sadr WM et al. The use of the Framingham equation to predict myocardial infarctions in HIV‐infected patients: comparison with observed events in the D:A:D Study. HIV Med 2006; 7: 218 – 230.
dc.identifier.citedreferenceFriis‐Moller N, Weber R, Reiss P et al. Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study. AIDS 2003; 17: 1179 – 1193.
dc.identifier.citedreferenceDAD. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356: 1723 – 1735.
dc.identifier.citedreferenceWanke CA, Falutz JM, Shevitz A, Phair JP, Kotler DP. Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus. Clin Infect Dis 2002; 34: 248 – 259.
dc.identifier.citedreferenceFerraioli G, Tinelli C, Maggi P et al. Arterial stiffness evaluation in HIV‐positive patients: a multicenter matched control study. AJR Am J Roentgenol 2011; 197: 1258 – 1262.
dc.identifier.citedreferenceMaggi P, Lillo A, Perilli F, Maserati R, Chirianni A, Group P. Colour‐Doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy: a comparative study. AIDS 2004; 18: 1023 – 1028.
dc.identifier.citedreferenceFarizo KM, Buehler JW, Chamberland ME et al. Spectrum of disease in persons with Human Immunodeficiency Virus infection in the United States. JAMA 1992; 267: 1798 – 1805.
dc.identifier.citedreferenceSterne JA, Hernan MA, Ledergerber B et al. Long‐term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 2005; 366: 378 – 384.
dc.identifier.citedreferencePalella FJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced Human Immunodeficiency Virus infection. New Engl J Med 1998; 338: 853 – 860.
dc.identifier.citedreferencePalella FJ, Baker RK, Moorman AC et al. Moratlity in the highly active antiretroviral therapy era, changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43: 27 – 34.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hiv12351_am.pdf
Size:
200.4KB
Format:
PDF
View/Open
Name:
hiv12351.pdf
Size:
162.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.